Dr. Zhavoronkov is the Founder and CEO of Insilico Medicine, Founder of Deep Longevity, and an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.
Dr. Zhavoronkov holds a master’s degree in biotechnology from Johns Hopkins and a PhD in Physics and Mathematics from Moscow State University.
Up Next in Health and Longevity
-
Tom Lemberg + Curebase
What if we could decentralize clinical trials, so that any patient, anywhere in the world, could participate?
That’s the mission of Curebase: making effective decentralized clinical trials a reality so that more people can participate in them.
The company’s software platform and virtual staff ...
-
Naveen Jain + Viome
Can we prevent or even reverse chronic diseases?
That’s the mission of Viome. The company’s platform analyzes all the biochemical activity in your body by looking at your saliva, blood, and stool to give you an accurate picture of your unique health… and combines this with predictive biomarker... -
Blake Marggraff + CareSignal
What if healthcare teams could use technology to identify patients with rising risks and prevent costly hospitalizations?
CareSignal’s remote patient monitoring platform and AI-based patient engagement technology enable care teams to get in touch with high-risk patients before their health wors...
